Literature DB >> 11045305

Surgical treatment for sclerosing encapsulating peritonitis.

H Kawanishi1, Y Harada, E Sakikubo, M Moriishi, T Nagai, S Tsuchiya.   

Abstract

Sclerosing encapsulating peritonitis (SEP) is recognized as a serious complication of continuous ambulatory peritoneal dialysis (CAPD). To date, in our hospital, 12 cases of SEP have been successfully treated by active intervention. The development of SEP was observed in these patients after removal of a peritoneal catheter. SEP was relieved by steroid administration in 3 of these patients, and by total parenteral nutrition (TPN) performed after exploratory laparotomy in 1 patient. In the remaining 8 patients, SEP was relieved by total intestinal enterolysis. In patients who underwent total intestinal enterolysis, the severity of encapsulation and adhesion varied. White, rigid encapsulation was observed in 4 patients who had been treated by peritoneal dialysis (PD) for less than 10 years. Seemingly normal serosae were observed under the capsules, and total intestinal enterolysis was easily performed in these patients. In the patient who underwent renal transplantation, more severe intestinal adhesion was observed, although the duration of PD was limited to 70 months and the intestinal serosae were seemingly normal. These findings were considered specific to SEP developing after immunosuppressant administration. In 3 patients who had undergone PD for more than 10 years, degeneration of the visceral peritoneum was observed, together with an ill-defined boundary between the capsules and the serosae. Therefore, total enterolysis was performed in these patients, including a wide area of the muscular layer. Furthermore, calcification was observed in several regions, where the capsules were severely adherent to the parietal peritoneum. The post-operative course for all 8 patients was satisfactory, and these patients finally returned to their previous social activities. We conclude that when SEP symptoms are not improved by steroid administration or TPN, active total intestinal enterolysis should be performed. However, it is absolutely important to avoid inducing anastomosis or impairing the intestine.

Entities:  

Mesh:

Year:  2000        PMID: 11045305

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  5 in total

1.  The promising future of long-term peritoneal dialysis.

Authors:  Dimitrios Oreopoulos; Elias Thodis; Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

2.  The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.

Authors:  Vincenzo La Milia; Selena Longhi; Elisabetta Sironi; Giuseppe Pontoriero
Journal:  J Nephrol       Date:  2016-12-24       Impact factor: 3.902

3.  Idiopathic encapsulating peritonitis: report of two cases.

Authors:  Magda Maria Profeta Da Luz; Sumara Marques Barral; Carlyle Marques Barral; Cristiane De Souza Bechara; Antônio Lacerda-Filho
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

4.  A case of fulminant sclerosing peritonitis presented like acute culture-negative peritonitis and successfully treated with corticosteroid therapy.

Authors:  Ji Yun Jung; Jong Tae Cho
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

5.  Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis.

Authors:  Ming-Shan Chang; Nai-Ching Chen; Chih-Yang Hsu; Chien-Wei Huang; Po-Tsang Lee; Kang-Ju Chou; Hua-Chang Fang; Chien-Liang Chen
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.